Herpes simplex virus type 1 has the ability to induce expression of a human gene cluster located on chromosome 19 upon infection. This gene cluster contains three fucosyltransferases (encoded by FUT3, FUT5 and FUT6) with the ability to add a fucose to an N-acetylglucosamine residue. Little is known regarding the transcriptional activation of these three genes in human cells. Intriguingly, herpes simplex virus type 1 activates all three genes simultaneously during infection, a situation not observed in uninfected tissue, pointing towards a virus specific mechanism for transcriptional activation. The aim of this study was to define the underlying mechanism for the herpes simplex virus type 1 activation of FUT3, FUT5 and FUT6 transcription. The transcriptional activation of the FUT-gene cluster on chromosome 19 in fibroblasts was specific, not involving adjacent genes. Moreover, inhibition of NFκB signaling through panepoxydone treatment significantly decreased the induction of FUT3, FUT5 and FUT6 transcriptional activation, as did siRNA targeting of p65, in herpes simplex virus type 1 infected fibroblasts. NFκB and p65 signaling appears to play an important role in the regulation of FUT3, FUT5 and FUT6 transcriptional activation by herpes simplex virus type 1 although additional, unidentified, viral factors might account for part of the mechanism as direct interferon mediated stimulation of NFκB was not sufficient to induce the fucosyltransferase encoding gene cluster in uninfected cells.
Introduction
In general, viral infection of permissive cells results in a shut-off of the synthesis of most host genes. This is true also for large human viruses, such as human herpesviruses. Yet, the transcription of a select number of host cell genes persists during viral replication, sometimes at higher rates than before viral infection. Hence, the mechanisms utilized by herpesviruses for regulating expression of host cell genes are selective: host genes not necessary for virus multiplication tend to be switched off whereas transcription of host genes that promote virus replication or viral colonization are unchanged or up-regulated (Smiley 2004) . One of the most prominent events in this context concerns a simultaneous activation of a family of human fucosyltransferase genes (FUT3, FUT5 and FUT6) whose transcription rate each may be increased by as much as three orders of magnitude following infection by a number of different herpesviruses (Nystrom et al. 2004 (Nystrom et al. , 2007 Norden et al. 2013 ). The human fucosyltransferase encoding genes located in tandem at chromosome 19p13.3, FUT3, FUT5 and FUT6 are closely related, sharing an 85% sequence similarity, and they are the result of gene duplication events ( Fig. 1) (Dupuy et al. 2002) . The genes have evolved into fucosyltransferases that are able to add a fucose to an N-acetylglucosamine, in either an α-1,3 or α-1,4 position to a type 1 or type 2 precursor (Dupuy et al. 1999) . These genes are likely to be associated with viral pathogenesis, as adding an α-1,3 fucose to a sialylated type 2 structure creates sialyl Lewis X (sLeX), which is known to bind selectins. Selectins are proteins at the inner endothelial wall of relevance for allowing various circulating cells to cross the endothelium and access adjacent tissue (Scott and Patel 2013) . Consequently, a herpesvirus with the capacity to promote expression of sLeX would be equipped with tools that would assist the infected cell to leave the circulation, thereby enabling spread of the virus to the underlying tissue. This mechanism has been shown for another human virus, the retrovirus human T-cell leukemia virus-1 (HTLV-1), where virus-induced surface-associated sLeX on virus-containing cells promoted viral colonization of the skin (Kannagi 2001) .
At present, little is known about the molecular mechanisms that permit human viruses to dramatically activate the transcription of a few human genes concomitantly with an almost complete virusorchestrated shutdown of expression of the vast majority of the host genes. This problem is even more intriguing in the perspective of FUT3, FUT5 and FUT6 on chromosome 19p13.3. This is due to the synchronous transcriptional activation of FUT3, −5 and −6 in herpesvirus-infected cells that stands in contrast to the otherwise individual regulation of these genes in normal tissue. Thus, FUT3 and FUT6 but not FUT5 are normally expressed in the small intestines, FUT6 is expressed in the salivary glands and only FUT3 is expressed in the lungs and the stomach (Cameron et al. 1995) . FUT5 expression is extremely limited in normal cells (Cameron et al. 1995) . Even when these FUT genes are pathologically induced, i.e., in various tumor cells, only one or two, but never all of the three are up-regulated (Cameron et al. 1995; Hanski et al. 1996; Dabrowska et al. 2005; Escrevente et al. 2006; Barthel et al. 2009; Carvalho et al. 2010) . The only known exception is hepatocytes (HepG2 cell line), where a study demonstrated that two hepatocyte nuclear factors (HNF1A and HNF4A) were able to indirectly activate all three FUT genes, although FUT5 expression in liver tissue may be weak (Cameron et al. 1995; Lauc et al. 2010) .
The aim of this study was to establish if the simultaneous induction of the FUT-gene cluster on chromosome 19 by herpes simplex virus type 1 (HSV-1) is a specific process regulated by the infectious cycle and to define the underlying mechanism for the observed transcriptional activation of fucosyltransferases in HSV-1-infected fibroblasts.
Results
HSV-1 specifically activate FUT3, −5 and −6 gene expression Diploid fibroblasts were infected with HSV-1 or mock infected for 9 h and the expression levels of NRTN, FUT6, FUT3, FUT5 and NDUFA11 were assessed by reverse transcription real-time PCR (RTqPCR). FUT3, −5 and −6 were all up-regulated in the HSV-1-infected cells compared to the mock-infected cells, whereas the adjacent genes NRTN and NDUFA11 were unaffected or down-regulated, respectively ( Fig. 2A) . Additionally, fibroblasts were treated with the histone deacetylase (class I, II and IV) inhibitor Trichostatin (TSA), a compound that cause relaxation of heterochromatin structures that enables increased transcriptional activation, for 9 h in the absence of viral infection and the expression levels were assessed. The TSAtreatment-activated transcription of NRTN, FUT6, FUT3 and FUT5 whilst moderately lowered the transcription of NDUFA11 compared to untreated cells (Fig. 2B) . TSA treatment was verified by measuring the expression levels of CD40 (Gregorie et al. 2009 ), which increased in all replicates after TSA treatment, although the number of replicates (n = 3) were too few to confer a statistically significant result (P = 0.13) (Supplementary Fig. 1 ).
Hepatocyte nuclear factors 1a and 4a are not expressed in fibroblasts
The only known transcription factors for induction of FUT5, −3 and −6 are hepatocyte nuclear factors 1α and 4α (HNF1α and HNF4α) in hepatocytes. Therefore, the expression of HNF1α and HNF4α were assessed in HSV-1-infected and mock-infected fibroblasts by RT-qPCR. Fibroblasts were infected with 10 plaque forming units/cell (10 PFU/cell) of HSV-1 or mock infected for 9 h. The Huh7.5 hepatocellular cell line was used as a control as HNF1α and HNF4α are known to regulate expression of the FUT6, −3 and −5 gene cluster in this cell type. There was no detectable mRNA expression of HNF1α or HNF4α in fibroblasts whereas high levels were found in the Huh7.5 control cells (Fig. 3) .
NFκB-inhibitors subverts HSV-1 induction of FUT5, −3 and −6 in fibroblasts Human diploid fibroblasts were infected with HSV-1 at 10 PFU/cell for 8 h in the presence of indicated concentrations of Panepoxydone, a drug that inhibits NFκB via inhibition of IkB phosphorylation in addition to FOXM1 inhibition (Arora et al. 2014) . Panepoxydone blocked, in a dose dependent manner, the transcriptional activation of FUT3, −5 and −6 in HSV-1 infected cells (Fig. 4A) . To further verify this finding, HSV-1-infected fibroblasts were treated with increasing concentrations of NFκB-activation inhibitor IV for 8 h. A modest reduction in FUT3, −5 and −6 expression could be observed in both the infected cells as well as in the mock-infected cells (Fig. 4B) . Thereafter, HSV-1-infected fibroblasts were treated with the FOXM1-inhibitor Thiostreptone for 8 h. Inhibition of FOXM1 did not reduce expression of FUT3, −5 and −6 in the HSV-1-infected cells. Only a modest reduction of FUT3 expression could be observed in the mock-infected fibroblasts (Fig. 4C ). There was no visible effect on cell viability of any of the applied drug concentrations as assessed by a MTS-assay ( Supplementary Fig. 2 ). Transcription of HSV-1 glycoprotein B (gB-1) was measured as a surrogate marker for viral replication. The drug treatments had no significant effect on gB-1 transcription ( Supplementary Fig. 3A , B and C).
The p65 subunit of NFκB is crucial for FUT-induction in HSV-1-infected fibroblasts
Analysis of the putative promoter regions of FUT6, −3 and −5 using the online tool UniProbe (http://thebrain.bwh.harvard.edu/nfkb/), revealed that the p65 subunit has multiple potential binding sites in all three promoter regions (Supplementary Table I ). To further verify the notion that NFκB is a crucial component for induction of FUT6, −3 and −5 transcription in HSV-1-infected cells, the expression of the p65 subunit was blocked by short interfering RNA (siRNA) transfection. Human fibroblasts were transfected with either p65 siRNA or a scrambled siRNA control and were then either infected with HSV-1 at 10 PFU/cell or mock infected. Down regulation of p65 mRNA after transfection with siRNA in HSV-1-infected cells was verified by RT-qPCR (Fig. 5A ). There was approximately 70% reduction in p65 mRNA levels after siRNA transfection. The protein levels of p65 and actin in transfected fibroblasts were determined by western blot (Fig. 5B ). The band intensity was used to calculate the fold reduction in p65 levels using actin as a loading control (Fig. 5C ). Approximately half of the p65 protein levels could be blocked by siRNA transfection. Next the IL-6 mRNA levels were measured in HSV-1-infected fibroblasts that were either transfected with p65 siRNA or transfected with a scrambled siRNA control. A significant reduction in IL-6 mRNA expression was observed upon p65 siRNA transfection in HSV-1-infected cells (Fig. 5D) . Finally, the expression of FUT3, −5 and −6 was assessed after p65 siRNA transfection, both in HSV-1 and mock-infected fibroblasts. There was a significant reduction of expression from all three fucosyltransferase encoding genes when p65 was targeted by siRNA in the HSV-1-infected cells (Fig. 5E ). Transcription of HSV-1 glycoprotein B was higher in the cells that were transfected with p65 siRNA compared to the cells transfected with scrambled siRNA control prior to viral infection ( Supplementary Fig. 3D ).
FUT3, −5 and −6 are not activated by interferon stimulation alone
Uninfected human fibroblasts were treated with NFκB stimulating interferon beta (IFNβ), interferon gamma (IFNγ) or IL1 beta (IL1β) at NFκB-activation inhibitor IV, n = 2 or (C) Thiostrepton, n = 2, at indicated concentrations for 1 h and thereafter mock or HSV-1 infected (10 MOI) for additional 7 h in the presence of the drugs. Statistics were done using two-way ANOVA and multiple comparison t-test, * < 0.05, ** < 0.01, *** < 0.001 and **** < 0.0001. the indicated concentration and the gene expression of CXCL10, FUT3, FUT5 and FUT6 was determined. The CXCL10 gene is known to be a target for NFκB transcriptional regulation and was induced by three orders of magnitude upon stimulation with IFNβ and IFNγ, while IL1β stimulation triggered its activation by more than two orders of magnitude after 6 h of stimulation. Conversely, FUT3, −5 and −6 were expressed at lower levels after 6 h of stimulation with IFNβ, IFNγ and IL1β (Fig. 6) . After 24 h of stimulation, the expression levels of FUT3, −5 and −6 were essentially the same in the interferon stimulated cells as in the un-stimulated control cells.
Discussion
Expression of the majority of human genes is down modulated upon infection with HSV-1 in order to facilitate expression of viral genes (Smiley 2004) . However, as many as 500 genes have been described to be up-regulated more than 3-fold in HSV-1 infected fibroblasts (Taddeo et al. 2004) . FUT3, along with FUT5 and FUT6, located in tandem on chromosome 19 are uniquely induced during HSV-1 infection in as much as they are normally separately regulated in uninfected cells, and they are under control of individual promoters (Cameron et al. 1995; Dabrowska et al. 2005) . Moreover, several HSV-1 proteins are involved in the reduction of heterochromatin formation on cellular chromosomes (Conn and Schang 2013) . Despite this, we demonstrate that the up-regulation of FUT3, FUT5 and FUT6 in HSV-1-infected fibroblasts is specific and does not involve the adjacent NRTN and NDUFA11 genes. Conversely, treating the cells with a histone deacetylase inhibitor will open the chromatin structure and facilitate access to the promoter regions for transcription factors, potentially leading to a general increase in transcription (Grunstein 1997) . When uninfected fibroblasts were treated with TSA, which inhibits histone deacetylases of class I, II and IV, transcription was induced not only from FUT3, FUT5 and FUT6 but also from NRTN, supporting the notion that in HSV-1-infected fibroblasts the FUT-gene cluster is specifically targeted for transcriptional up-regulation.
FUT3 and FUT6 are both described to be involved in cancer cell metastasis and apoptosis (Mas et al. 1998; Togayachi et al. 1999; Le Pendu et al. 2001; Barthel et al. 2009) , and the promoter regions have been investigated in various cancer cell types (Dabrowska et al. 2005; Serpa et al. 2006; Higai et al. 2008 ). FUT5 expression is, however, very limited in normal tissue, and not much is known regarding its transcriptional activation. Studies on the FUT3 promoter suggest that the AP-1 transcription factor (Dabrowska et al. 2005 ) and promoter methylation (Serpa et al. 2006 ) are able to Transcription of IL-6 was determined using RT-qPCR in HEL cells transfected with siRNA targeting p65 or with a scrambled siRNA control and subsequently mock or HSV-1 infected (MOI 10), n = 4. (E) Transcription levels of FUT6, FUT3 and FUT5 mRNA in HEL cells transfected with siRNA targeting p65 or with a scrambled siRNA control and subsequently mock or HSV-1 infected for 7 h (MOI 10), n = 4, determined using RT-qPCR. Statistics were done using two-way ANOVA and multiple comparison t-test and unpaired t-test, * < 0.05, ** < 0.01, *** < 0.001 and **** < 0.0001. Fig. 6 . Stimulation of NFκB using interferon treatment fail to induce the FUTgene cluster in the absence of HSV-1-infection. To control whether the FUT genes were induced by activation of the NFκB pathway, the expression of CXCL10, FUT6, FUT3 and FUT5 was determined by RT-qPCR in uninfected cells treated with 200 units/mL IFNβ, 10 ng/mL IFNγ or 50 ng/mL IL1β for 6 or 24 h. regulate FUT3 expression. Promoter methylation has previously been shown not to be involved in FUT up-regulation of HSV-1 infected fibroblasts (Norden et al. 2010 ). AP-1 may however be relevant in HSV-1 infected cells as ICP0, an immediate early HSV-1 gene essential for a productive HSV-1 infection, stimulates AP-1 dependent transcription (Zachos et al. 1999; Diao et al. 2005 ). Thus, AP-1 may be involved in the transcriptional activation of FUT3, but not FUT5 or FUT6, which have dissimilar promoter regions (Dabrowska et al. 2005) . In contrast, the FUT5 and FUT6 promoter could be regulated by HNF1α, HNF4α and Oct-1 (Higai et al. 2008; Kel et al. 2008; Lauc et al. 2010 ) but we show here that HNF1α and HNF4α are not expressed in fibroblasts, either HSV-1-infected or uninfected, thus making them unlikely as master regulators of the FUT-gene cluster in this cell type.
It has previously been shown that the dsRNA-sensor protein kinase R (PKR) is necessary for HSV-1 induced activation of FUT3, −5 and −6 in fibroblasts ). In response to viral infection, PKR undergoes auto-phosphorylation, which drives signaling through multiple pathways, and one of the downstream targets is NFκB (Gil et al. 2000; Su et al. 2006) . In this study, it is demonstrated that treatment of fibroblasts with NFκB inhibiting drugs reduce HSV-1-induced transcriptional activation of the FUT-gene cluster. The notion that NFκB is a key element is further strengthened as blocking the p65 subunit of NFκB by siRNA transfection also prevented HSV-1-mediated FUT3, −5 and −6 transcription. Interestingly, blocking the p65 subunit with siRNA appeared to facilitate increased viral replication as the expression of the late gene gB-1 was significantly higher in these cells, possibly reflecting a damped antiviral state in the absence of fully functional NFκB signaling. Thus, even though the replication of HSV-1 may be enhanced in cells with reduced expression of p65 the transcription of FUT3, FUT5 and FUT6 is down modulated, further highlighting the importance of NFκB for transcriptional regulation of these fucosyltransferases in HSV-1-infected cells.
Furthermore, ubiquitination has been described to regulate NFκB (Chen and Chen 2013) , and inhibition of ubiquitindegradation of proteins by proteasomal inhibitor MG-132 also prevents HSV-1 induced transcription of FUT3, −5 and −6 . A detailed study of the DNA binding capacity of the five different NFκB subunits (c-Rel, p65, RelB, p50/p105 and p52/ p100) has resulted in the development of an online tool to search promoter sequences for NFκB binding sites (Siggers et al. 2011) . In silico analysis of a 3 kb region 5′ of the ATG start site of FUT3, −5, and −6 demonstrated p65 binding sites in the potential promoter region of all three genes. Together, these data indicate that transcription of FUT3, −5 and −6 is regulated by p65 in HSV-1-infected fibroblasts. However, the residual transcription of FUT3, -5 and -6 mRNA in the uninfected cells was not significantly affected by blocking p65 NFκB. This may be due to an additional effect by p52, which is regulated by the non-canonical NFκB pathway (Oeckinghaus and Ghosh 2009) . Moreover, potential binding sites for p52 are also found in the putative promoter regions of FUT3, -5 and -6 as determined by the in silico analysis (Supplementary Table I ). In addition, treatment of uninfected fibroblasts with IFNβ, IFNγ or IL1β was not sufficient to induce transcription of the FUTgene cluster. The interferon treatment was adequate for generating a strong CXCL10 response indicating that the NFκB pathway was activated through p50/p65, which is the main downstream effector complex in the NFκB pathway of these three drugs. IFNβ, IFNγ and IL1β mediated transcription through NFκB may differ from the observed p65-dependent pathway by which HSV-1 induced the FUT genes, as many varying regulatory events ranging from the seven different members of the IkB family to the posttranslational phosphorylation or acetylation allowing for a fine-tuned NFκB response (Oeckinghaus and Ghosh 2009) . Alternatively, additional viral factors may also be necessary for driving transcription of the FUT-gene cluster during HSV-1 infection in fibroblasts. Thus, the phenomenon we describe here, where HSV-1 simultaneously induce transcription of FUT3, FUT5 and FUT6 via NFκB, may be the sum of several separate events, which only take place during herpesvirus infection.
Materials and methods

Virus and cells
The Syn17+ strain of HSV-1 was used throughout the study. Plaque titration on green monkey kidney cells (GMK) was used to determine the viral concentrations, which allowed for calculation of plaque forming units per cell (PFU/cell). Human embryonic lung fibroblasts were cultivated in Eagle's minimal essential medium (EMEM) supplemented with 10% fetal calf serum, 1% pencillinstreptomycin and 1% L-glutamine.
Drug treatment and viral infection
The cells were grown in 6-well plates (9 cm 2 per well) until they were confluent. Fresh growth media supplemented with drugs at indicated concentrations was added to the cells, and the plates were incubated for 1 h at 37°C and 5% CO 2 in a humid chamber. Subsequently HSV-1 (Syn17+) was added at a multiplicity of infection 10 (MOI 10), and the virus was allowed to attach to the cells for 1 h at 37°C and 5% CO 2 in a humid chamber. For mock infection, the cells were instead incubated with virus free growth medium. Unbound viral particles were removed by washing the cells with buffered NaCl solution. Growth medium supplemented with the indicated drug concentrations was again added to the cells and incubation was continued for 6 h. At the end of the incubation, the growth medium was removed and the cells were harvested by adding 600 μL lysis buffer, consisting of Nucleic acid purification lysis solution (Applied Biosystems, Waltham, MA) and phosphate-buffered saline at a ratio of 1:1, to each well. The samples were subsequently stored at -20°C until RNA extraction. The following drugs were used in the study: panepoxydone (Sigma Aldrich, Saint Louis, MO), NFκB-activation inhibitor IV (Calbiochem, Billerica, MA), (1×) reduced serum medium and incubated at room temperature for 10 min before combined with the prepared siRNA complexes. The final mix was incubated for an additional 20 min at room temperature. The cells to be transfected with siRNA were grown in growth medium without antibiotics in a 12-well plate until they were 50% confluent. The growth medium was removed and the cells washed once with EMEM (1% L-glutamine) before addition of 300 μL of EMEM (1% L-Glu) and 190 μL oligonucleotide-mix to each well. The cells were incubated for 4 h in 37°C and 5% CO 2 . Subsequently 250 μL EMEM (1% L-Glu, 2% fetal calf serum) was added to each well without removal of the transfection mixture. The incubation was allowed to continue for 72 h. The transfected cells were then either harvested for protein purification by removing the growth medium and adding 240 μL 1× sample buffer (4 mL dH 2 O, 1 mL Tris-HCl (0.5 M, pH 6.8), 0.8 mL Glycerol, 1.6 mL SDS 10% (w/v), 0.4 mL 2-mercaptoethanol, 0.2 mL saturated bromphenol blue-solution) and removal of the cells using a cell scraper, or mock and HSV-1 infected as described above. Finally, the infected cells were harvested for nucleic acid purification as described in the section "Drug treatment and viral infection".
Nucleic acid extraction
The samples, stored in lysis solution, were thawed and the nucleic acids purified using the 6100 Nucleic acid PrepStation (Applied Biosystems, Waltham, MA) and a Total RNA isolation kit (Applied Biosystems, Waltham, MA) or RNeasy Mini Prep Kit (Qiagen, Hilden, Germany) both according to the manufacturer instructions. To further purify RNA, the total nucleic acids were subjected to DNase treatment using the TURBO DNA-free™ Kit (Thermo Fisher Scientific, Waltham, MA) according to the manufacturer instructions. The RNA concentration was determined using a NanoDrop ® ND-1000 spectrophotometer or a Qubit ® 2.0 Fluorometer, and adjusted to 10-20 ng/μL using dH 2 O.
Reverse transcription real-time PCR
The gene expression levels were assessed by reverse transcription realtime PCR (RT-qPCR). All reactions were set up as follows: Superscript ® III Platinum 2X mastermix (Invitrogen, Carlsbad, CA) was mixed with 0.5 mM forward and reverse primer, 0.3 mM probe, 20-40 ng RNA and H 2 O in a total volume of 20 μL. The reaction conditions were as follows: one step at 50°C for 30 min, one step at 95°C for 10 min, 40 PCR cycles at 95°C for 15 s and 60°C for 60 s. The primer and probe sequences for FUT3, FUT5, FUT6, 18S and gB-1 have been described previously (Nystrom et al. 2004; Norden et al. 2009 ), primers and probes for HNF1A, HNF4A, CXCL10, IL-6, CD40 and p65 were purchased from Thermo Fisher Scientific (Waltham, MA). The primer and probe sequences for NRTN and NDUFA11 were as follow: NDUFA11 forward primer, 5′-AAG GAG TGG CTA AGG TGG AC-3′; NDUFA11 reverse primer, 5′-CAC CGA GGA AGT AGT TCA GG-3′; NDUFA11 probe, FAM-5′-CCT CAC CAC CTG CAT CAG CGC CCA-3′-TAMRA; NRTN forward primer, 5′-CTG GAT GTG TCG AGA GGG C-3′; NRTN reverse primer, 5′-AGC TCC ATC GCA TCC GG-3′; NRTN probe, FAM-5′-CTT CTC AGC CAC CGC CTC GGA CCT GC-3′-TAMRA. The results from the RT-qPCR assays were calculated with the ΔC T method based on the formula C R = 2 −ΔCT+X and 18S was used as a reference gene (Nystrom et al. 2004 ).
Western blot
The samples were heated to 95°C for 10 min and subjected to three sonication cycles (30 s ON/30 s OFF) using the Bioruptor ® Pico
Sonication system (Diagenode, Seraing, Belgium) before separation of the proteins in a gel (NuPage 4-12% Bis-Tris gel, Novex, Thermo Fisher Scientific, Waltham, MA). The proteins were subsequently blotted to a polyvinylidene fluoride membrane (Millipore, Billerica, MA). The membrane was blocked in 5% Bovine Serum Toxicity test (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide assay)
3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide reduction assays were performed to determine the cell viability after drug treatment. Human fibroblasts were grown in 96-well plates and drugs were applied at the indicated concentrations. The cells were incubated at 37°C and 5% CO 2 for 14 h in a humid chamber. Subsequently 20 μL Cell Titer 96 ® Aqueous One Solution Cell
Proliferation Assay (Promega, Fitchburg, MA) was added to each well and the plate was incubated for 2 h as above before determining the absorbance at 492 nm.
Statistical analysis
The statistical analysis was performed using either unpaired t-test or two-way analysis of variance (two-way ANOVA) followed by multiple comparison using GraphPad Prism 6 (GraphPad Software Inc., La Jolla, CA). A P-value <0.05 was considered significant.
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